Shusen Zhang

Dr. Shusen Zhang


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SZShusen Zhang
Shusen Zhang
YLYuanyuan Lu
Yuanyuan Lu
LQLei Qi
Lei Qi
HWHongyan Wang
Hongyan Wang
ZWZhihua Wang
Zhihua Wang
ZCZhigang Cai
Zhigang Cai
Background. Lung adenocarcinoma (LUAD), as the main subtype of lung cancer, is one of the common causes of cancer‐related deaths worldwide. The AHNAK family is correlated with cell structure and migration, cardiac calcium channel signaling, and tumor metastasis. Previous studies showed AHNAK2 could promote tumor progression and cell migration in melanoma and renal clear cell carcinoma. However, the role of AHNAK2 in LUAD remains unknown. Methods. We examined the levels of AHNAK2 in pathological specimens and the database of Clinical Proteomic Tumor Analysis Consortium‐Lung adenocarcinoma (CPTAC‐LUAD), The Cancer Genome Atlas‐Lung Adenocarcinoma (TCGA‐LUAD), Gene Expression Omnibus dataset (GSE72094, GSE26939), and The Genotype‐Tissue Expression (GTEx) of lung tissue samples. Univariate Cox regression, multivariate Cox regression, and Kaplan–Meier survival analysis were performed to reveal the relationship between AHNAK2 and prognosis. A nomogram was constructed to predict 2‐ or 3‐year overall survival and validated via calibration curves, receiver operating characteristic (ROC) analysis, and decision curve analysis (DCA). Furthermore, Gene Ontology (GO) analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were used to explore the functional role of AHNAK2 in lung adenocarcinoma. Finally, by transfecting siRNA, we examined the regulatory effect of AHNAK2 on cell migration. Results. The expression of AHNAK2 was upregulated in tumor samples and correlated with poor prognosis in LUAD patients. Nomogram with AHNAK2 and clinical parameters showed a good prediction in overall survival (OS), especially the 2‐year OS. In addition, functional analyses and wound healing assay suggested that AHNAK2 might be involved in the regulation of migration in LUAD. Conclusion. In summary, our study showed that AHNAK2 might be a novel biomarker in LUAD and revealed the potential mechanism of AHNAK2 in LUAD progression which could provide new insights for target therapy.

1 March 2016 in Pathology - Research and Practice
Verified
Journal Article
Closed access
TZTingting Zhang
Tingting Zhang
XZXiubing Zhang
Xiubing Zhang
WSWeidong Shi
Weidong Shi
JXJian Xu
Jian Xu
HFHui Fan
Hui Fan
RNRunzhou Ni
Runzhou Ni

13 September 2024 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
TXTao Xu
Tao Xu
CLChengyu Liu
Chengyu Liu
XNXuecong Ning
Xuecong Ning
ZGZhiguo Gao
Zhiguo Gao
ALAimin Li
Aimin Li
PZPing Zhang
Ping Zhang
Idiopathic pulmonary fibrosis (IPF) is a progressive and debilitating respiratory disease with a median survival of less than 5 years. In recent years, glutamine has been reported to be involved in the regulation of collagen deposition and cell proliferation in fibroblasts, thereby influencing the progression of IPF. However, the relationships between glutamine and the incidence, progression, and treatment response of IPF remain unclear. Our study aimed to investigate the relationship between circulating glutamine levels and IPF, as well as its potential as a therapeutic target. We performed a comprehensive Mendelian Randomization (MR) analysis using the most recent genome-wide association study summary-level data. A total of 32 single nucleotide polymorphisms significantly correlated to glutamine levels were identified as instrumental variables. Eight MR analysis methods, including inverse variance weighted, MR-Egger, weighted median, weighted mode, constrained maximum likelihood, contamination mixture, robust adjusted profile score, and debiased inverse-variance weighted method, were used to assess the relationship between glutamine levels with IPF. The inverse variance weighted analysis revealed a significant inverse correlation between glutamine levels and IPF risk (Odds Ratio = 0.750; 95% Confidence Interval : 0.592–0.951; P = 0.017). Sensitivity analyses, including MR-Egger regression and MR-PRESSO global test, confirmed the robustness of our findings, with no evidence of horizontal pleiotropy or heterogeneity. Our study provides novel evidence for a causal relationship between lower circulating glutamine levels and increased risk of IPF. This finding may contribute to the early identification of high-risk individuals for IPF, disease monitoring, and development of targeted therapeutic strategies.

16 December 2025 in BMC Nephrology
Verified
Journal Article
Open access
PDF file
JHJingjing Hou
Jingjing Hou
HLHaitao Li
Haitao Li
FNFu Niu
Fu Niu
XMXiaodan Mu
Xiaodan Mu
SZShusen Zhang
Shusen Zhang
ZCZhigang Cai
Zhigang Cai
Obstructive fibrinous tracheal pseudomembrane (OFTP) is a relatively rare complication of endotracheal intubation. It can develop with short-term intubatio